Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6887467

Title:Double mutants of dihydrofolate reductase and methods of using same
Inventors:Bertino, Joseph R.; New York, NY, USA
Ercikan-Abali, Emine A.; New York, NY, USA
Banerjee, Debabrata; New York, NY, USA
Mineishi, Shin; New York, NY, USA
Sadelain, Michel; New York, NY, USA
Summary:Described herein are human dihydrofolate reductase double mutants, and methods and uses thereof. The double mutants are described as having substitutions at positions 22 and 31, and with properties superior to the previously disclosed mutants. Specific mutant forms include Ser31Tyr22, Ser31Phe22, Gly31Tyr22, Gly31Phe22, Ala31Tyr22 and Ala31Phe22. Methods are described by which the mutant DHFR may be used as a selectable marker, and in the modification of the genome of human cells, particularly bone marrow cells or peripheral blood stem cells. Therapeutic applications are included, such as in protecting bone marrow or blood stem cells from chemotherapy using antifolate agents.
Abstract:New mutant forms of human dihydrofolate reductase (DHFR) which have properties superior to the previously disclosed mutants have mutations at both amino acid 22 and amino acid 31. Specific mutant forms are Ser31Tyr22, Ser31Phe22, Gly31Tyr22, Gly31Phe22, Ala31Tyr22 and Ala31Phe22. The mutant DHFR of the invention may be used as a selectable marker, and to modify the genome of human cells, particularly bone marrow cells or peripheral blood stem cells, to render them resistant to chemotherapy using antifolate agents.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6887467
Application Number:US2003000650417
Date Filed:27/08/2003
Date Published:03/05/2005
Assignee:Sloan-Kettering Institute for Cancer Research, New York, NY, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/22/2021